Psychologist Glen Spielmans of Metropolitan State University, St Paul, Minnesota, and colleagues analysed adverts aimed at medical professionals in four prominent US journals – including the New England Journal of Medicine, one of the most widely-read journals in the world.
42 out of the 53 ads (nearly 80 per cent) the researchers examined made at least one claim the team couldn’t substantiate. 27 made a claim that was not supported by the data source cited by the ad. A further 15 contained claims that couldn’t be verified by the team – usually because the ads provided no sources of data to back up their claims, or made claims that could not be verified because drug firms either failed to respond to the researchers’ requests for trial data, or refused to supply it.
“The sources are provided by the companies themselves, so it’s pretty easy to cherry pick one study that backs up their claim,” Spielmans told Chemistry World. “Despite that, many of the cited sources did not support the advertising claims.”
Spielmans says his findings contradict the pharmaceutical industry’s contention that drug ads serve to educate doctors about the benefits and risks of drugs. “Education would typically be based on evidence,” he notes. “If it’s not based on evidence, it’s not education.”
Jon Edwards | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences